Why Quantum Computing (QUBT), Nano Nuclear Energy (NNE) and Tempus AI (TEM) Are Popping Higher Today
With markets showing signs of life again, some of the most oversold stocks are going along for the ride. That includes Quantum Computing (NASDAQ:QUBT), Nano Nuclear (NASDAQ:NNE) and Tempus AI (NASDAQ:TEM | TEM Price Prediction). Chaay_Tee / iStock via Getty…
With markets showing signs of life again, some of the most oversold stocks are going along for the ride. That includes Quantum Computing (NASDAQ:QUBT), Nano Nuclear (NASDAQ:NNE) and Tempus AI (NASDAQ:TEM | TEM Price Prediction).
Quantum Computing
Shares of Quantum Computing spiked earlier after the company announced the sales of one of its EmuCore reservoir computers to a major automotive manufacturer.
This helps validate Quantum Computing’s technology in real-world applications.
As noted by Dr. William McGann, Chief Executive Officer of QCi, “We’re excited to support one of the world’s leading automotive innovators with the delivery of our EmuCore reservoir computing device. This sale represents a meaningful validation of our technology in real-world environments and is yet another example of the increasing demand we’re seeing for our devices and offerings in diverse markets.”
Nano Nuclear Energy
Shares of Nano Nuclear Energy are also blasting higher with the overall market.
Last trading at $19.40, we’d like to see it retest $30.
Helping, the company recently announced that “the U.S. Nuclear Regulatory Commission updated the University of Illinois Urbana-Champaign project landing page surrounding the KRONOS MMR Energy System pre-application engagement, officially designating NANO Nuclear as the reactor’s designer,” as noted in a company press release.
Tempus AI
Weeks ago, Tempus AI took off on news Nancy Pelosi picked up 50 of the TEM January 2026 $20 call options. It also got a boost from Cathie Wood and Ark Invest buying 445,958 shares.
Fueling even more upside, analysts at BTIG initiated coverage of TEM with a buy rating with a price target of $60. “Tempus possesses one of the largest molecular libraries of cancer patients in the world and aims to be one of very few companies to monetize it. We believe the company’s AI applications (algos) and data business represent a significant free call option for investors,” said the firm, as quoted by CNBC.
Contact [email protected] for any questions or corrections.
Ian Cooper is a veteran market analyst and investment strategist with more than 20 years of experience covering stocks, commodities, and macro trends. Since 1999, he has helped investors identify market opportunities using a blend of technical analysis, fundamental research, and market sentiment.
He is the creator of the ADD News Flow Strategy, which focuses on trading market reactions to major news events and investor psychology. Cooper was also among the analysts who warned about the 2008 financial crisis and major financial institution collapses ahead of the broader market.
Before joining 247 Wall St., Cooper wrote extensively for InvestorPlace and other financial publications, covering market trends, trading strategies, and investment opportunities.
